Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes.

To determine whether regulation of fasting endogenous glucose production (EGP) and glucose disappearance (R(d)) are both abnormal in people with type 2 diabetes, EGP and R(d) were measured in 7 "severe" (SD), 9 "mild" (MD), and 12 nondiabetic (ND) subjects (12.7 +/- 0.6 vs. 8.1 +/- 0.4 vs. 5.1 +/- 0.4 mmol/l) after an overnight fast and during a hyperglycemic pancreatic clamp. Fasting insulin was higher in both the SD and MD than ND subjects, whereas fasting glucagon only was increased (P < 0.05) in SD. Fasting EGP, glycogenolysis, gluconeogenesis, and R(d) all were increased (P < 0.05) in SD but did not differ in MD or ND. On the other hand, when glucose ( approximately 11 mmol/l), insulin ( approximately 72 pmol/l), and glucagon ( approximately 140 pg/ml) concentrations were raised to values similar to those observed in the severe diabetic subjects, EGP was higher (P < 0.001) and R(d) lower (P < 0.01) in both SD and MD than in ND. The higher EGP in the SD and MD than ND during the clamp was the result of increased (P < 0.05) rates of glycogenolysis (4.2 +/- 1.7 vs. 3.5 +/- 1.0 vs. 0.0 +/- 0.8 micromol.kg(-1).min(-1)), since gluconeogenesis did not differ among groups. We conclude that neither glucose production nor disappearance is appropriate for the prevailing glucose and insulin concentrations in people with mild or severe diabetes. Both increased rates of gluconeogenesis (likely because of higher glucagon concentrations) and lack of suppression of glycogenolysis contribute to excessive glucose production in type 2 diabetics.

[1]  H. Beck-Nielsen,et al.  On the determination of basal glucose production rate in patients with Type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion , 1990, Diabetologia.

[2]  F. Assimacopoulos-Jeannet,et al.  Differential effect of steady-state hyperinsulinaemia and hyperglycaemia on hepatic glycogenolysis and glycolysis in rats , 1987, Diabetologia.

[3]  R. Rizza,et al.  Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans. , 2003, Diabetes.

[4]  R. Rizza,et al.  Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles. , 2003, American journal of physiology. Endocrinology and metabolism.

[5]  J. Radziuk,et al.  Quantitation of basal endogenous glucose production in Type II diabetes: importance of the volume of distribution , 2002, Diabetologia.

[6]  M. Mozzoli,et al.  FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. , 2002, American journal of physiology. Endocrinology and metabolism.

[7]  I. Gabriely,et al.  Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects. , 2002, Diabetes.

[8]  C. Chu,et al.  Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs. , 2002, American journal of physiology. Endocrinology and metabolism.

[9]  K. Nair,et al.  Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. , 2002, Diabetes.

[10]  E. Ferrannini,et al.  Determination of the enrichment of the hydrogen bound to carbon 5 of glucose on 2H2O administration. , 2001, Analytical biochemistry.

[11]  B. Landau Methods for measuring glycogen cycling. , 2001, American journal of physiology. Endocrinology and metabolism.

[12]  L. Rossetti,et al.  Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism. , 2001, Diabetes.

[13]  J. Radziuk,et al.  Production and metabolic clearance of glucose under basal conditions in Type II (non-insulin-dependent) diabetes mellitus , 2001, Diabetologia.

[14]  E. Ferrannini,et al.  Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. , 2001, Diabetes.

[15]  M. Jensen,et al.  Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. , 2001, Diabetes.

[16]  M. Mozzoli,et al.  Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. , 2001, Diabetes.

[17]  T P Stein,et al.  Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. , 2001, American journal of physiology. Endocrinology and metabolism.

[18]  R. Bergman,et al.  Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin. , 2000, American journal of physiology. Endocrinology and metabolism.

[19]  E. Ferrannini,et al.  Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. , 2000, Diabetes.

[20]  G. Shulman,et al.  Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. , 2000, Diabetes.

[21]  C Cobelli,et al.  Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. , 1998, Diabetes.

[22]  M. Vranic,et al.  Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans. , 1998, The American journal of physiology.

[23]  K. Petersen,et al.  Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. , 1998, The Journal of clinical investigation.

[24]  J. Wahren,et al.  Quantifying gluconeogenesis during fasting. , 1997, American journal of physiology. Endocrinology and metabolism.

[25]  E. Volpi,et al.  Evidence of Increased Systemic Glucose Production and Gluconeogenesis in an Early Stage of NIDDM , 1997, Diabetes.

[26]  C Cobelli,et al.  Impaired Basal Glucose Effectiveness in NIDDM: Contribution of Defects in Glucose Disappearance and Production, Measured Using an Optimized Minimal Model Independent Protocol , 1997, Diabetes.

[27]  C. Chu,et al.  The Role of Fatty Acids in Mediating the Effects of Peripheral Insulin on Hepatic Glucose Production in the Conscious Dog , 1997, Diabetes.

[28]  M. Vranic,et al.  Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients. , 1996, The Journal of clinical endocrinology and metabolism.

[29]  J. Wahren,et al.  Contributions of gluconeogenesis to glucose production in the fasted state. , 1996, The Journal of clinical investigation.

[30]  H. Gin,et al.  Measurement of post‐absorptive glucose kinetics in non‐insulin‐dependent diabetic patients: methodological aspects , 1996, European journal of clinical investigation.

[31]  G. Boden,et al.  Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. , 1995, The Journal of clinical investigation.

[32]  W. Sheu,et al.  Relationship Between Hepatic Glucose Production and Fasting Plasma Glucose Concentration in Patients With NIDDM , 1994, Diabetes.

[33]  F. Féry Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: normalization of glucose kinetics by short-term fasting. , 1994, The Journal of clinical endocrinology and metabolism.

[34]  E. Barrett,et al.  Insulin and glucose suppress hepatic glycogenolysis by distinct enzymatic mechanisms. , 1993, Metabolism: clinical and experimental.

[35]  N. Barzilai,et al.  Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. , 1993, The Journal of clinical investigation.

[36]  R. Shulman,et al.  Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. , 1992, The Journal of clinical investigation.

[37]  H. Beck-Nielsen,et al.  Insulin resistance, but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus. , 1991, Acta endocrinologica.

[38]  L. Groop,et al.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.

[39]  B. Hansen,et al.  Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys. , 1989, The American journal of physiology.

[40]  R. DeFronzo,et al.  Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. , 1989, Metabolism: clinical and experimental.

[41]  G. Brechtel,et al.  Effects of Fasting on Plasma Glucose and Prolonged Tracer Measurement of Hepatic Glucose Output in NIDDM , 1987, Diabetes.

[42]  N. Abumrad,et al.  Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo. , 1987, Diabetes/metabolism reviews.

[43]  R. Rizza,et al.  Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus. , 1986, The New England journal of medicine.

[44]  R. Rizza,et al.  Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. , 1986, The Journal of clinical investigation.

[45]  R. DeFronzo,et al.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. , 1985, The Journal of clinical investigation.

[46]  B V Howard,et al.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. , 1984, The Journal of clinical investigation.

[47]  E. Rayfield,et al.  Transhepatic glucagon gradients in man: evidence for glucagon extraction by human liver. , 1984, The Journal of clinical endocrinology and metabolism.

[48]  J. Thiessen,et al.  High-pressure liquid chromatographic analysis of indocyanine green. , 1982, Journal of pharmaceutical sciences.

[49]  J. A. Scarlett,et al.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. , 1981, The Journal of clinical investigation.

[50]  L. Mandarino,et al.  Dose-response characteristics for effects of insulin on production and utilization of glucose in man. , 1981, The American journal of physiology.

[51]  G. Shulman,et al.  Differential Time Course of Glucagon's Effect on Glycogenolysis and Gluconeogenesis in the Conscious Dog , 1981, Diabetes.

[52]  K. Tranberg Hepatic uptake of insulin in man. , 1979, The American journal of physiology.

[53]  W. Blackard,et al.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. , 1975, The Journal of clinical investigation.

[54]  W. Blackard,et al.  Portal and Peripheral Vein Immunoreactive Glucagon Concentrations After Arginine or Glucose Infusions , 1974, Diabetes.

[55]  R. Steele,et al.  Measurement of size and turnover rate of body glucose pool by the isotope dilution method. , 1956, The American journal of physiology.

[56]  박귀태,et al.  A Type 2 Diabetes–Associated Functional Regulatory Variant in a Pancreatic Islet Enhancer at the ADCY5 Locus , 2017, Diabetes.